Janssen Cilag Famacutica
⚠️ Moderate Risk
FEI: 3005811260 • Sao Paulo, Sao Paulo • BRAZIL
FEI Number
3005811260
Location
Sao Paulo, Sao Paulo
Country
BRAZILAddress
Rua Gerivatiba 207, , Sao Paulo, Sao Paulo, Brazil
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
Frequently Asked Questions
What is Janssen Cilag Famacutica's FDA import refusal history?
Janssen Cilag Famacutica (FEI: 3005811260) has 2 FDA import refusal record(s) in our database, spanning from 10/6/2009 to 7/26/2010.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Janssen Cilag Famacutica's FEI number is 3005811260.
What types of violations has Janssen Cilag Famacutica received?
Janssen Cilag Famacutica has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Janssen Cilag Famacutica come from?
All FDA import refusal data for Janssen Cilag Famacutica is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.